Biofabrication strategies for 3D in vitro models and regenerative medicine
- PMID: 31223488
- PMCID: PMC6586020
- DOI: 10.1038/s41578-018-0006-y
Biofabrication strategies for 3D in vitro models and regenerative medicine
Abstract
Organs are complex systems composed of different cells, proteins and signalling molecules that are arranged in a highly ordered structure to orchestrate a myriad of functions in our body. Biofabrication strategies can be applied to engineer 3D tissue models in vitro by mimicking the structure and function of native tissue through the precise deposition and assembly of materials and cells. This approach allows the spatiotemporal control over cell-cell and cell-extracellular matrix communication and thus the recreation of tissue-like structures. In this Review, we examine biofabrication strategies for the construction of functional tissue replacements and organ models, focusing on the development of biomaterials, such as supramolecular and photosensitive materials, that can be processed using biofabrication techniques. We highlight bioprinted and bioassembled tissue models and survey biofabrication techniques for their potential to recreate complex tissue properties, such as shape, vasculature and specific functionalities. Finally, we discuss challenges, such as scalability and the foreign body response, and opportunities in the field and provide an outlook to the future of biofabrication in regenerative medicine.
Conflict of interest statement
Competing interests The authors declare no competing interests.
Figures








Similar articles
-
Enhancing Peptide Biomaterials for Biofabrication.Polymers (Basel). 2021 Aug 4;13(16):2590. doi: 10.3390/polym13162590. Polymers (Basel). 2021. PMID: 34451130 Free PMC article. Review.
-
Biomaterial-based 3D bioprinting strategy for orthopedic tissue engineering.Acta Biomater. 2023 Jan 15;156:4-20. doi: 10.1016/j.actbio.2022.08.004. Epub 2022 Aug 10. Acta Biomater. 2023. PMID: 35963520 Review.
-
[Biofabrication: new approaches for tissue regeneration].Handchir Mikrochir Plast Chir. 2018 Apr;50(2):93-100. doi: 10.1055/s-0043-124674. Epub 2018 Jan 29. Handchir Mikrochir Plast Chir. 2018. PMID: 29378379 Review. German.
-
Advances in 3D bioprinting for regenerative medicine applications.Regen Biomater. 2024 Mar 26;11:rbae033. doi: 10.1093/rb/rbae033. eCollection 2024. Regen Biomater. 2024. PMID: 38845855 Free PMC article. Review.
-
Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering.J Cardiovasc Dev Dis. 2021 Oct 22;8(11):137. doi: 10.3390/jcdd8110137. J Cardiovasc Dev Dis. 2021. PMID: 34821690 Free PMC article. Review.
Cited by
-
Osteoblast/fibroblast coculture derived bioactive ECM with unique matrisome profile facilitates bone regeneration.Bioact Mater. 2020 Jun 30;5(4):938-948. doi: 10.1016/j.bioactmat.2020.06.017. eCollection 2020 Dec. Bioact Mater. 2020. PMID: 32637756 Free PMC article.
-
Mechanical and Biological Characterization of Ionic and Photo-Crosslinking Effects on Gelatin-Based Hydrogel for Cartilage Tissue Engineering Applications.Polymers (Basel). 2024 Sep 27;16(19):2741. doi: 10.3390/polym16192741. Polymers (Basel). 2024. PMID: 39408454 Free PMC article.
-
Synergistic Therapeutic Potential of Dual 3D Mesenchymal Stem Cell Therapy in an Ischemic Hind Limb Mouse Model.Int J Mol Sci. 2023 Sep 27;24(19):14620. doi: 10.3390/ijms241914620. Int J Mol Sci. 2023. PMID: 37834069 Free PMC article.
-
Generalizing hydrogel microparticles into a new class of bioinks for extrusion bioprinting.Sci Adv. 2021 Oct 15;7(42):eabk3087. doi: 10.1126/sciadv.abk3087. Epub 2021 Oct 15. Sci Adv. 2021. PMID: 34652944 Free PMC article.
-
In vitro, ex vivo, and in vivo models for dental pulp regeneration.J Mater Sci Mater Med. 2023 Apr 1;34(4):15. doi: 10.1007/s10856-023-06718-2. J Mater Sci Mater Med. 2023. PMID: 37004591 Free PMC article. Review.
References
-
- Gomes ME, Rodrigues MT, Domingues RMA & Reis RL Tissue engineering and regenerative medicine: new trends and directions-a year in review. Tissue Eng. Part B Rev 23, 211–224 (2017). - PubMed
-
- Tschugg A et al. A prospective randomized multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disk plus autologous disk chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disks to avoid secondary disease: safety results of Phase I-a short report. Neurosurg. Rev 40, 155–162 - PMC - PubMed
-
- Martin I et al. The survey on cellular and engineered tissue therapies in Europe in 2013. Tissue Eng. A 22, 5–16 (2016). - PubMed
-
- Groll J et al. Biofabrication: reappraising the definition of an evolving field. Biofabrication 8, 013001 (2016). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources